Moolec Science Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020
Cash & Equivalents	2.53	1.08	0.14	0.01
Short-Term Investments	0.31	0	0	0
Cash & Cash Equivalents	2.83	1.08	0.14	0.01
Cash Growth	161.94%	688.70%	2134.29%	-
Receivables	10.45	0	0	0
Inventory	0.47	0	0	0
Other Current Assets	-8.42	0	0.02	0.31
Total Current Assets	5.33	1.08	0.16	0.31
Property, Plant & Equipment	1.19	0.01	0	0
Long-Term Investments	0	0	138.01	0
Goodwill and Intangibles	8.77	4.6	0	0
Other Long-Term Assets	8.76	0	0	0
Total Long-Term Assets	18.72	4.61	138.01	0
Total Assets	24.05	5.69	138.17	0.31
Accounts Payable	7.48	1.23	0.99	0.17
Current Debt	2.55	2.86	0.13	0.13
Other Current Liabilities	2.57	0	0	0.01
Total Current Liabilities	12.6	4.09	1.12	0.3
Long-Term Debt	0.1	0	0	0
Other Long-Term Liabilities	1.25	0	2.2	0
Total Long-Term Liabilities	1.35	0	2.2	0
Total Liabilities	13.95	4.09	3.31	0.3
Total Debt	2.65	2.86	0.13	0.13
Debt Growth	-7.51%	2188.00%	-	-
Retained Earnings	-58.62	-6.83	-3.14	-0.01
Comprehensive Income	0.02	0	0	0
Shareholders' Equity	10.11	1.6	-3.14	0.01
Net Cash / Debt	0.19	-1.78	0.01	-0.12
Net Cash Per Share	-	-0.10	0.00	-0.04
Working Capital	-7.27	-3	-0.96	0.01
Book Value Per Share	0.27	0.09	-0.19	0.00

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).